Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens Boots Alliance Inc. WBA, +1.78% shares rose 1.6% in Monday premarket trading after the pharmacy retailer reported fourth-quarter earnings and sales that beat expectations.

Walgreens shares rise after earnings beat

Apple

Chevron

Pfizer

Exxon Mobil

Merck

Six of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.

Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week

Johnson & Johnson

Teva Pharmaceutical

Don’t play the headlines and don’t make the mistake of lumping all opioid stocks together.

2 Sells and 1 Buy in Opioid Stocks

Walgreens Boots Alliance Inc (NASDAQ: WBA) is scheduled to announce its fiscal fourth-quarter results on Oct.

JPMorgan Downgrades Walgreens, Says Near-Term Growth Likely To Remain Challenged

Shares of Walgreens Boots Alliance Inc. WBA, -1.93% dropped 1.9% in morning trading Wednesday, after J.P.

Walgreens's stock falls after J.P. Morgan abandons bullish stance, lowers price target

FedEx

FedEx Express (NYSE: FDX) on Friday used an unmanned aerial vehicle instead of a truck for last-mile residential deliveries on behalf of pharmacy retailer Walgreens (NASDAQ: WBA).

Wing Teams Up With FedEx, Walgreens For Milestone Drone Delivery

CVS Health

With UPS and Google sister company Wing as partners, the big pharmacies are starting to deliver pills, Cheez-Its, and first aid supplies by drone.

CVS and Walgreens’s drones are finally here—and they’re bringing Band-Aids

Persistent de-emphasizing of tobacco is hurting growth, which should get reflected in the upcoming quarterly results of Walgreens Boots Alliance (WBA).

Is Walgreens Boots (WBA) Likely to Disappoint in Q4 Earnings?

Centene

Walgreens Boots Alliance, Centene and the pharmacy benefit manager RxAdvance are launching a cloud-based pharmacy management platform.

Walgreens Partners With Centene And AdvanceRx On Cloud PBM Deal

Home Depot

Microsoft

With the run-up in price from the late December, 2018 lows, some Dow components have rallied to higher prices than last year’s peaks and some are having trouble keeping up.

The Strongest Components Of The Dow Jones Industrial Average — And The Weakest

Air Products and Chemicals

Roper Technologies

SEI Investments

To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years.

5 Dividend Aristocrats Where Analysts See Capital Gains

UnitedHealth Group

Health Care Select Sector SPDR Fund

The stock market is having a banner year, despite the trade war with China and worries about a looming economic slowdown. But health care stocks aren't taking part in the rally.

Glum days have arrived for health care stocks

Archer-Daniels-Midland Company

Cardinal Health

Caterpillar

Genuine Parts

AT&T

Investors planning for retirement have a significant challenge on their hands, which is to generate enough income to maintain their desired lifestyle, explains Ben Reynolds, a leading specialist on income, a contributor to MoneyShow.com and the editor of Sure Dividend.

7 Safe Dividend Aristocrats For Growing Retirement Income

FedEx and Walgreens are partnering to make online returns more convenient, in a move that’s a part of a growing trend where brick-and-mortar retailers are catering to the needs of e-commerce shoppers in order to increase foot traffic at their stores. Under the new agreement, consumers will be able to drop off their online returns […]

Walgreens partners with FedEx to accept online returns, print labels

Walgreens Boots Alliance (WBA) closed the most recent trading day at $52.28, moving -0.91% from the previous trading session.

Walgreens Boots Alliance (WBA) Stock Moves -0.91%: What You Should Know

Big Lots

Kroger

Stocks are trading below Peter Lynch value and have good business predictability.

3 Defensive Retail Companies to Consider as US Producer Prices Decline

FedEx Corp. (NYSE: FDX) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) made a huge announcement on Tuesday that will make it easier for customers to drop off returns at thousands of Walgreens across the United States.

Meet the New FedEx and Walgreens Partnership Ahead of the Holidays

FedEx Corp. FDX, -1.61% announced Tuesday a partnership with Walgreens Boots Alliance Inc.

FedEx partners with Walgreens, to allow package returns at Walgreens stores

This collaboration is in line with Walgreens' (WBA) commitment toward providing affordable and convenient healthcare facilities to residents of North Carolina.

Walgreens Inks Retail Health Collaboration Deal With Novant

Walgreens Boots Alliance said it will stop sales of e-cigarettes at all of its U.S. drugstores as regulatory scrutiny of vaping intensifies.

Walgreens To Stop Sales Of E-Cigarettes As Scrutiny Of Vaping Intensifies

Bank of America

Booz Allen Hamilton Hld

Cigna

CoreCivic

GEO Group

Alphabet

Gap Inc

Lockheed Martin

Northrop Grumman

Papa John's

Wells Fargo

J.P. Morgan's list includes U.S. companies that would be affected by policy initiatives in areas like anti-trust, financial regulation, climate change, healthcare reform and minimum wage, among others.

These stocks could have the most to lose if a progressive Democratic agenda takes hold in 2020

Delta Air Lines

Levi Strauss

Domino's Pizza

Fastenal

Infosys

The markets are in the quiet period before the third-quarter earnings reporting season, but a few prominent companies will be sharing their results this week.

Delta Air Lines, Levi Strauss, Walgreens and More Earnings Coming This Week

Walgreens Boots Alliance Inc. WBA, -1.10% said Wednesday it was collaborating with Postmates for on-demand delivery of over-the-counter medications and wellness, beauty and grocery products in New York City.

Walgreens, Postmates team up on deliveries in New York City

Walgreens Boots Alliance (WBA) closed the most recent trading day at $54.70, moving -1.1% from the previous trading session.

Walgreens Boots Alliance (WBA) Stock Moves -1.1%: What You Should Know

Walgreens Boots Alliance stock just ran up to a historically bearish trendline

News for Walgreens Stock (WBA)